MediFind

Find a Doctor

Maryam B. Lustberg

Osu Internal Medicine LLC
Oncology, Hematology, Internal Medicine
Female
Practicing approx. 17 years

Bio


Maryam Lustberg is an Oncologist and an Internal Medicine specialist in Dublin, Ohio. She has been an author on 117 peer reviewed articles and participated in 7 clinical trials in the past 15 years. Dr. Lustberg's top three areas of expertise are Breast Cancer, Peripheral Neuropathy, and Paget Disease of the Breast. She is licensed to treat patients in OH.

Contact

3900 Stoneridge Ln
Dublin, OH 43017, US

Latest Research


Latest Advance
Study
  • Condition: Breast Cancer
  • Journal: Journal of cancer survivorship : research and practice
  • Treatment Used: Proton Pump Inhibitors (PPIs)
  • Number of Patients: 551
  • Published —
This study considered patients with breast cancer who were treated with proton pump inhibitors (medication to reduce stomach acid production; PPIs) in order to evaluate cognitive outcomes among these patients.
Latest Advance
Study
  • Condition: Genitourinary Syndrome of Menopause
  • Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
  • Treatment Used: Fractional CO2 Laser Therapy
  • Number of Patients: 64
  • Published —
This study tested the safety and efficacy of using fractional CO2 laser therapy to treat patients with genitourinary syndrome of menopause.
Latest Advance
Study
  • Condition: Advanced Solid Tumors
  • Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
  • Treatment Used: Two Chimeric HER-2 B-Cell Peptide Vaccines Emulsified in Montanide ISA 720VG and Nor-MDP Adjuvant
  • Number of Patients: 49
  • Published —
This study advanced a new paradigm in immunotherapy that focuses on humoral responses based on conformational B-cell epitope vaccines for patients with advanced solid tumors.

Clinical Trials


Clinical Trial
Drug
  • Status: Not yet recruiting
  • Study Type: Drug
  • Participants: 30
  • Start Date: November 1, 2020
Pilot Trial of Acute Effect of Lorcaserin to Reduce Patient-Reported Symptoms of Taxane- and Oxaliplatin-Induced Peripheral Neuropathy
Clinical Trial
Other
  • Status: Recruiting
  • Participants: 200
  • Start Date: June 14, 2019
Chemotherapy Induced Peripheral Neuropathy Natural History Study (EPIPHANY)
Clinical Trial
Behavioral
  • Status: Recruiting
  • Study Type: Behavioral
  • Participants: 40
  • Start Date: March 4, 2019
Curcumin for Breast Cancer Survivors With Aromatase Inhibitor-Induced Joint Arthropathy - A Randomized, Double-Blinded, Controlled Pilot Study
Clinical Trial
Dietary Supplement
  • Status: Recruiting
  • Study Type: Dietary Supplement
  • Participants: 120
  • Start Date: October 12, 2016
Prevention of Aromatase Inhibitor-Induced Toxicity With Omega-3 Supplementation
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 60
  • Start Date: June 23, 2015
Randomized Placebo Controlled Study of Minocycline for Amelioration of Chemotherapy Induced Affective Disorders

All Publications
View All


Publication
Study
  • Journal: Neuro-oncology advances
  • Published —
Multidisciplinary patient-centered management of brain metastases and future directions.
Publication
Study
  • Journal: Reviews of physiology, biochemistry and pharmacology
  • Published —
Solute Carrier Transportome in Chemotherapy-Induced Adverse Drug Reactions.

Contact

3900 Stoneridge Ln
Dublin, OH 43017, US

Affiliations

  • James Cancer Hospital & Solove Research Institute
  • Ohio State University State Health System

Credentials

  • Graduate InstitutionUniversity Of Maryland School Of Medicine
    2003
  • Licenses
    Internal Medicine in OH
  • Board Certifications
    Hematology/oncology

Insurance

Contact them to find out if they accept your insurance plan.